Granules India gets USFDA nod for naproxen sodium tablet

23 Sep 2011 Evaluate

Granules India has received approval from the US Food and Drug Administration (FDA) for its naproxen sodium tablet, the generic version of Bayer AG’s Aleve pain relieving medicine,

The company is producer of active pharmaceutical ingredients (API's) and pharmaceutical formulation intermediates (PFIs) with complete vertical integration. They expertise in manufacturing PFIs which are Directly Compressible Granules has helped customers to move to the next level of outsourcing in the pharmaceutical industry.

Granules India Share Price

603.30 -14.00 (-2.27%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×